Tygh Capital Management, Inc. - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 308 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.69 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tygh Capital Management, Inc. ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$3,430,000
-58.6%
34,489
-60.4%
0.53%
-66.0%
Q3 2020$8,292,000
-40.7%
86,995
-30.5%
1.57%
-46.1%
Q2 2020$13,993,000
+26.8%
125,101
-17.6%
2.92%
+17.9%
Q1 2020$11,038,000
+90.1%
151,792
+172.7%
2.47%
+158.0%
Q4 2019$5,806,000
+78.1%
55,672
+70.0%
0.96%
+65.6%
Q3 2019$3,260,000
-52.3%
32,748
-45.3%
0.58%
-50.1%
Q2 2019$6,831,000
+12.0%
59,838
+23.3%
1.16%
+8.2%
Q1 2019$6,101,000
-43.9%
48,536
-39.5%
1.07%
-53.0%
Q4 2018$10,881,000
+2.8%
80,183
+108.0%
2.28%
+31.7%
Q3 2018$10,584,000
+2.6%
38,557
-22.6%
1.73%
-0.9%
Q2 2018$10,316,000
+23.6%
49,793
-1.4%
1.75%
+10.2%
Q1 2018$8,343,000
+24.8%
50,514
+3.4%
1.58%
+26.0%
Q4 2017$6,687,000
-36.8%
48,837
-37.2%
1.26%
-40.5%
Q3 2017$10,588,000
+47.4%
77,767
+31.5%
2.12%
+30.0%
Q2 2017$7,181,00059,1551.63%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
BVF INC/IL 2,626,160$138,136,00024.17%
KNOTT DAVID M 1,292,566$67,988,972,00013.87%
GROW Partners, LLC 200,000$10,520,0006.41%
Opaleye Management Inc. 90,000$4,860,000,0003.82%
OBERWEIS ASSET MANAGEMENT INC/ 213,317$11,220,0002.72%
First Light Asset Management, LLC 60,242$3,169,0002.69%
Timpani Capital Management LLC 98,956$5,205,0002.59%
Iguana Healthcare Management, LLC 75,000$3,945,0002.25%
Eventide Asset Management 134,400$7,069,0002.18%
ASHFORD CAPITAL MANAGEMENT INC 215,223$11,321,0002.16%
View complete list of LIGAND PHARMACEUTICALS INC shareholders